New stent graft approach aims to treat High-Risk aortic aneurysm patients

NCT ID NCT06526676

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether specially modified stent grafts can safely treat complex aortic aneurysms (bulges in the main blood vessel) in people who are too high-risk for traditional open surgery. Researchers will track 50 patients to see how many have serious complications like death, stroke, or kidney failure, and whether the grafts work well over time. The goal is to find a less invasive option for these difficult cases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Physician-modified stent grafts (Cook Alpha TX2, Zenith TX2, Zenith Fenestrated)
What this could lead to
If successful, this could offer a safer, less invasive treatment option for people with complex aortic aneurysms who cannot undergo open surgery.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply to everyone. There are serious risks like death, stroke, or kidney failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUXTARENAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California, Los Angeles

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.